Emtricitabine

Emtricitabine (Emtriva) is an antiretroviral drug used to treat HIV infection. It is a reverse transcriptase inhibitor, which works by blocking the activity of reverse transcriptase, an enzyme essential to the replication of HIV. It is used in combination with other drugs to treat HIV and to prevent the spread of HIV. Emtricitabine is taken orally in the form of a tablet and is approved for use by adults and children over the age of two.

Emtricitabine is a medication used to treat HIV infection. Here's a closer look at its function and uses:

Function: Emtricitabine belongs to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs). HIV uses an enzyme called reverse transcriptase to copy its genetic material (RNA) into DNA so it can infect healthy cells. Emtricitabine works by interfering with this process. It blocks the reverse transcriptase enzyme, preventing the virus from replicating and helping control the HIV infection.

Uses:

  • Emtricitabine is not used alone but rather in combination with other antiretroviral medications for the treatment of HIV infection in adults and children.
  • It may also be used, along with safer sex practices, to help prevent HIV infection in people at high risk (pre-exposure prophylaxis or PrEP).

Important Considerations:

  • Not a Cure: Emtricitabine doesn't cure HIV infection, but it helps control the virus and slow disease progression.
  • Combination Therapy: Emtricitabine is always used with other HIV medications to prevent the virus from developing resistance to the drugs.
  • Side Effects: Emtricitabine can cause side effects, although some people may not experience any. Common side effects include headache, diarrhea, and nausea.

Brand Names:

Emtricitabine is available under the brand names:

  • Emtriva® (as a single medication)
  • Truvada® (in combination with tenofovir disoproxil fumarate)
  • Descovy® (in combination with tenofovir alafenamide)

Disclaimer: This information is for educational purposes only and shouldn't be substituted for professional medical advice. Always consult your doctor for diagnosis and treatment recommendations for HIV infection or PrEP.

Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AF Nucleoside and nucleotide reverse-transcriptase inhibitors
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
External Links